Employers are facing uncertainty as to the expiration of the COVID-19 relief the U.S. Department of Labor (DOL) and Internal Revenue Service (IRS) issued in a joint guidance on May 4, 2020.
The joint guidance requires employee benefit plans to toll, or suspend, certain deadlines during the “Outbreak Period,” which the guidance defines as the period beginning on March 1, 2020, and ending on the date that is “60 days after the announced end of the National Emergency or such other date announced by the [departments].” As noted in the joint guidance, the DOL’s and IRS’s statutory authority permits only a one-year extension of these deadlines.
The deadlines that are subject to the suspension or extension during the Outbreak Period include the following:
- The period within which special enrollment in the employer’s group health plan must be requested (for example, the deadline to enroll a new spouse or child);
- Deadlines related to continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA), including the 60-day election period, the timing of payments for COBRA continuation coverage, and the period within which individuals must notify the plan of a second COBRA qualifying event or determination of disability;
- The date by “which individuals may file a benefit claim under the plan’s claims procedure” (often 365 days from the date the claim was incurred);
- The date by which claimants may file an appeal of a denied claim under the plan’s claims procedure (often 180 days from the date they receive notice of claim denial);
- The four-month period within which claimants in a non-grandfathered group health plan “may file a request for an external review after receipt of an adverse benefit determination or final internal adverse benefit determination”; and
- The date by which a claimant in a non-grandfathered group health plan “may file information to perfect a request for external review upon a finding that the request was not complete” (the later of the original four-month period or 48 hours after receiving notice of the incomplete filing).
Because the national emergency has not ended and neither the DOL nor IRS has weighed in regarding the expiration of the relief provided in the joint guidance, employers are left without official guidance on administration of their benefit plans with respect to the deadlines outlined above.
Employers could take one of two approaches in determining how the expiration of the relief in the joint guidance impacts the above deadlines:
- Approach One
The Outbreak Period expires on February 28, 2021, for all of the deadlines listed above, and the clock on those deadlines begins to run again on March 1, 2021. Here is an example:
- June 1, 2020: The participant gave birth.
- July 1, 2020: This is the normal deadline by which the participant must request enrollment for the child in the participant’s group health plan.
- Because the participant gave birth during the Outbreak Period, her special enrollment period under the Health Insurance Portability and Accountability Act (HIPAA) is tolled until the March 1, 2021, expiration of the regulatory relief.
- March 1, 2021: On this date, the participant’s HIPAA special enrollment period begins.
- March 31, 2021: This is the participant’s last day to enroll her child in the plan. The enrollment would be effective retroactively back to June 1, 2020, assuming all required premiums are paid.*
*If a participant takes advantage of the deadline extension and enrolls a child after the normal 30-day deadline, there may be multiple months of premiums to be paid shortly after the end of the Outbreak Period. Participants may not be able to make such payments, but it is not clear that they would be granted further extensions to pay the make-up payments (particularly with respect to insured benefits). The same issue arises with respect to make-up COBRA premium payments. Guidance from the DOL and IRS in this regard would be welcome.
Note that “clocks” that were running on March 1, 2020, would not reset to 0 on March 1, 2021, but would simply restart on that date. For example, if a participant gave birth on February 15, 2020, (meaning 14 days ran off the clock before March 1, 2020), the participant would only have 16 days, beginning on March 1, 2021, to enroll her child in the plan under the first approach.
- Approach Two
The one-year limitation in the joint guidance applies to each deadline separately (i.e., on a case-by-case basis). This interpretation leads to a different result:
- June 1, 2020: The participant gave birth.
- July 1, 2020: This is the normal deadline by which a participant must request enrollment for a child in the participant’s group health plan.
- Unless the president or the IRS and the DOL announce an earlier end to the Outbreak Period, the participant’s HIPAA special enrollment period is tolled for one year, until June 1, 2021.
- June 1, 2021: This is the date on which the participant’s HIPAA special enrollment period begins.
- July 1, 2021: This is the participant’s last day to enroll her child in the plan. The enrollment would be effective retroactively back to June 1, 2020, assuming all required premiums are paid.
During an informal conversation, one IRS agent indicated that there was the possibility of a 60-day “pad” after March 1, 2021, which would essentially toll the above deadlines by another 60 days after March 1, 2021. Although the Internal Revenue Code contains a possible statutory justification for this position for the IRS, there is no similar provision in the Employee Retirement Income Security Act (ERISA) for the DOL. It is possible that the above issues will be addressed in an updated joint guidance from the IRS and the DOL.
Next Steps
Employers will want to consider how to proceed with respect to these deadlines, particularly if there is no intervening guidance from the departments. The more conservative approach may be for employers to operate their benefit plans as if the clock on the deadlines set forth above restarts on March 1, 2021. Employers may also want to consider distributing communications targeted to participants who are affected by the expiration of the deadline extensions.
Ogletree Deakins will continue to monitor IRS and DOL publications and report on developments with respect to the COVID-19 pandemic and will post updates on the firm’s Coronavirus (COVID-19) Resource Center as additional information becomes available. Important information for employers is also available via the firm’s webinar and podcast programs.